GPR 120: The Potential Target for Obesity Treatment

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|16|1|8-11

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.1, 2016-03, pp. : 8-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of GPR120: a patent review

By Halder Somnath   Kumar Sanjay   Sharma Rajiv  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1581-1590

Informa Healthcare

Access to resources Recommend Favorite

Ghrelin as a Potential Anti-Obesity Target

By  

Current Pharmaceutical Design, Vol. 9, Iss. 17, 2003-07 ,pp. : 1383-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Potential use of exenatide for the treatment of obesity

By Folli Franco   Guardado Mendoza Rodolfo  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1717-1722

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Obesity: Should We Target the Individual or Society?

By  

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1151-1163

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics: potential role in the treatment of diabetes and obesity

By Vella Adrian   Camilleri Michael  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1109-1119

Informa Healthcare

Access to resources Recommend Favorite